Title : Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.

Pub. Date : 2017 Nov

PMID : 28905400






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro studies indicated that treatment with the BIM-23926 sst1 agonist, as well as SSTR1 overexpression, decreased, whereas SSTR1 silencing increased, cell-proliferation in 22Rv1 cells, likely through the regulation of PI3K/AKT-CCND3 signaling-pathway. bim cyclin D3 Homo sapiens